chazzy1
7 days ago
LocWolf, I have not checked in on this board in a few days, so I am just now seeing the exchange you had with sunspotter. I do appreciate your kind words in reference to me. I think that sunspotter knows that I have no affiliation with VPLM or HDVY other than as a retail shareholder. He and I have expressed some diametrically opposing viewpoints from time to time, and I must agree with you that he writes some rather compelling arguments. Sunspotter does have executive level business experience, and generally knows what he is talking about. However, I have never believed that HDC or VoIP-Pal were "scam" companies solely out to defraud their shareholders, and I still do not believe that. Maybe I am just naive, but I do know that after landing a settlement agreement with Intel (which shocked sunspotter), HDC's board hired a new CEO with a stellar reputation in business development bio-engineering to monetize HDC's IP. Just how successful Dr. Hauser can be with his mission remains to be seen, but a scam? No.
VoIP-Pal has been fighting a lengthy, uphill battle within a legal system that is clearly stacked against the patent owner. There are two patent infringement cases in Waco, Texas that are currently awaiting a response from Judge Albright on a motion for reconsideration, filed by VP's legal team. I happen to agree with VP attorney, Hudnell, that Judge Albright made some serious errors of law (e.g., citing the wrong precedent, and getting confused about the claim construction terms in his initial ruling of non-infringement). However, not winning a court case that was repleat with reversable errors does not make VoIP-Pal a scam. They could actually still get a favorable ruling on this. But as things stand currently, sunspotter appears to be more correct than me, however, it is too early to call a winner as both games are still in play and the underdogs could still win. When and if that happens, I will be far less surprised than sunspotter. JMHO.
chazzy1
3 weeks ago
LocWolf, you are certainly right about having a sense of humor. It can be therapeutic as it helps us cope with difficult situations when we are at a loss for answers. I do not believe that Alan has "left the building" as they say. Besides, a definitive material event like that would necessitate another 8 K filing. I think it is safe to assume that he is at work trying to make things happen that would bring value to shareholders, of which he is one. I would love to be a fly on the wall in his office, and eavesdrop on his conversations. It might be very interesting and possibly exciting. Like everyone else here, I am getting antsy for some kind of news, I must admit.
Be well! Chazzy1
chazzy1
3 weeks ago
Well said, ou71764, and I agree with your thoughts. There are people with more at stake in this investment than me, and the guy at the helm knows a lot more about HDC's technology than me, so there is little I can do except just sit back and enjoy the ride. But you are 100% correct in that HDC's top priority should be to bring the company into full compliance with the SEC, so that HDVY is relisted for retail trading ASAP.
Good Sport
2 months ago
https://www.sec.gov/ix?doc=/Archives/edgar/data/1141788/000168316824006475/health_8k.htm
8K is just out. Pretty straight forward on dismissal...
"Item 8.01 Other Events
On September 13, 2024, the United States District Court for the Northern District of Georgia granted Health Discovery Corporation’s (“HDC” or the “Company”) motion for summary judgment in full and entered judgment in favor of all defendants on all counts in the shareholder derivative lawsuit brought by Vennwest Global Technologies, Inc. (“Vennwest”). The Vennwest lawsuit, which was initially filed in September 2020, alleged misconduct by the Company and its board of directors (“Board”) in connection with approving a series of loans to HDC by certain directors and shareholders of HDC. The Vennwest lawsuit contains virtually identical claims against HDC that shareholders William Quirk and Cindy Bear had alleged, which lawsuit was also dismissed. The loans at issue were sought by the Company to allow it to meet its financial obligations in connection with litigation that was ongoing at the time. The District Court found that the loans were presented to and approved by the Board, in all respects, in compliance with Georgia’s conflicting interest transaction statutes, requiring the dismissal of all claims asserted by the plaintiff. The judgment affords HDC the recovery of its costs associated with the lawsuit (which does not include the recovery of its legal fees).
The Court’s order and judgment represent a complete refutation of these baseless claims and a total vindication of the Company’s longstanding position that these claims were entirely without merit and served only to distract the Company and deplete its resources to the detriment of its shareholders.
Board member Colleen Hutchinson stated: “We are gratified by the decision of the Court in this matter. Now that this matter has been resolved, the Board looks forward to focusing on the development of the Company’s technology without the unnecessary distraction and cost that this lawsuit has caused over the previous four years.”
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
HEALTH DISCOVERY CORPORATION
Registrant
Dated: September 18, 2024 By: /s/ Colleen Hutchinson
Colleen Hutchinson
Board Member